dr. chavez on ongoing efficacy and challenges with ibrutinib in cll
Published 6 years ago • 238 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
0:56
dr. chavez discusses ibrutinib plus venetoclax in cll
-
0:41
dr. chavez on combination of ibrutinib plus ublituximab in cll
-
9:02
efficacy and future role of ibrutinib in cll and mcl
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
2:12
dr. brander on the safety and efficacy of ibrutinib/venetoclax in cll
-
0:51
dr. seymour on role of ibrutinib in cll
-
1:33
dr. jacobs on the efficacy of ibrutinib and acalabrutinib in patients with mcl
-
2:15
dr. kay discusses the role of ibrutinib in cll
-
1:41
dr. logan discusses acalabrutinib in cll
-
7:13
using ibrutinib in chronic lymphocytic leukemia (cll)
-
1:29
dr. james on update of ibrutinib for chronic lymphocytic leukemia
-
1:45
dr. fakhri on ibrutinib-containing regimens in cll
-
1:31
dr. smith on the rationale behind the fixed duration trial for ibrutinib/venetoclax in cll
-
1:13
dr. nastoupil on triplet of tgr1202, ublituximab, and ibrutinib in cll
-
1:16
dr. wierda on ibrutinib plus venetoclax in cll
-
3:39
long-term efficacy and safety with ibrutinib in cll
-
2:09
dr. sharman on the phase iii results of the genuine study in cll
-
0:55
dr. pinilla-ibarz on ibrutinib's efficacy in treating high-risk patients with cll
-
1:25
dr. wierda discusses the role of ibrutinib in cll